Continuation of Treatment in Children With ADHD: A Multicenter Turkish Sample Study

Basit Öğe Kaydı
dc.authoridBozkurt, abdullah/0000-0002-8359-6131
dc.authoridCobanoglu Osmanli, Cansu/0000-0002-9631-1262
dc.contributor.authorBaykal, Saliha
dc.contributor.authorOsmanli, Cansu Cobanoglu
dc.contributor.authorBozkurt, Abdullah
dc.contributor.authorOnal, Bedia Sultan
dc.contributor.authorSahin, Berkan
dc.contributor.authorKaracizmeli, Muge
dc.contributor.authorGazi, Aysegul Oz
dc.date.accessioned2024-10-29T17:58:49Z
dc.date.available2024-10-29T17:58:49Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractObjectives: The aim of this study was to investigate the variables that may affect treatment continuation in children aged 6 to 12 years who were newly diagnosed with ADHD.Methods: A total of 132 children diagnosed with ADHD and their parents participated in the study. Sociodemographic and clinical risk factors affecting continuation of treatment were examined using logistic regression analysis.Results: Multiple model examination revealed that greater age increased the risk of treatment discontinuation 1.824 times (p = .003) while a lower total length of paternal education increased the risk of discontinuation (1/0.835) 1.198 times (p = .022). Other variables emerging as significant in the univariate model lost that significance in the multiple model.Conclusions: Understanding the variables associated with medication discontinuation in ADHD in different populations and taking these variables into account in the development of health policies, will be useful in improving the long-term devastating effects of the disorder.
dc.identifier.doi10.1177/10870547231222021
dc.identifier.endpage1424
dc.identifier.issn1087-0547
dc.identifier.issn1557-1246
dc.identifier.issue11en_US
dc.identifier.pmid38294169
dc.identifier.scopus2-s2.0-85184232195
dc.identifier.scopusqualityQ1
dc.identifier.startpage1415
dc.identifier.urihttps://doi.org/10.1177/10870547231222021
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14511
dc.identifier.volume28
dc.identifier.wosWOS:001153550500001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.ispartofJournal of Attention Disorders
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectADHD
dc.subjectmethylphenidate
dc.subjectatomoxetine
dc.subjectmedication continuity
dc.titleContinuation of Treatment in Children With ADHD: A Multicenter Turkish Sample Study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu